Zdrowie i gospodarka · 06/04/2004

FDA Amends Regulations for Emergency IND Submissions

The Food and Drug Administration (FDA) is updating its rules to reflect a change in contact information for submitting an investigational new drug application (IND) in emergency situations, aiming to improve the accuracy of its regulations.